Ives Sees SpaceX-Tesla Merger Signal in Terafab Project, Targets 55% TSLA Upside
Wedbush Securities managing director Dan Ives is making a bold strategic call: Tesla's newly announced Terafab artificial intelligence chip manufacturing project is a harbinger of a potential merger with SpaceX, potentially occurring as early as 2027. Maintaining an "OUTPERFORM" rating on the electric vehicle manufacturer, Ives has set a $600 price target on $TSLA shares—implying nearly 55% upside from current trading levels around $383. The ambitious Terafab initiative, designed to produce between 100,000 to 1 million wafer starts monthly to address explosive AI compute demand, represents a transformative strategic pivot that extends Tesla's technological dominion beyond traditional automotive manufacturing.
The analysis underscores a growing thesis among Wall Street observers that Elon Musk's various enterprise holdings are becoming increasingly interconnected, with chip manufacturing capability serving as a potential bridge asset. However, not all prominent investors are convinced the merger narrative is positive for Tesla shareholders. Gary Black, a prominent EV investor and Tesla bull, has issued a cautionary counterpoint, warning that a potential SpaceX-Tesla combination could result in 20-25% stock dilution, potentially triggering long-term exits from the EV-focused investment community.
The Terafab Project and Strategic Implications
The Terafab initiative represents one of the most ambitious domestic semiconductor manufacturing projects announced by a non-traditional chip manufacturer. Key parameters of the initiative include:
- Production capacity target: 100,000 to 1 million wafer starts per month
- Primary objective: Meeting surging artificial intelligence compute demand
- Investment scale: Approximately $25 billion in total project value
- Strategic positioning: Vertical integration of AI chip production within Tesla's ecosystem
This move positions Tesla to reduce dependence on external semiconductor suppliers—a critical vulnerability exposed during the global chip shortage of 2021-2022. By controlling its own advanced chip manufacturing, Tesla could accelerate development of autonomous driving systems, AI-powered vehicle features, and next-generation computing platforms. The timing is particularly significant given the exponential growth in AI inference and training compute requirements globally.
Ives' analysis suggests that Terafab serves as more than a standalone manufacturing facility; it represents a logical convergence point between Tesla's automotive and energy storage businesses with SpaceX's satellite internet and aerospace computing needs. The overlap in semiconductor requirements across both enterprises—particularly for edge computing, autonomous systems, and high-reliability applications—creates a compelling economic rationale for consolidated chip manufacturing operations.
Market Context and Merger Precedent
The potential SpaceX-Tesla merger hypothesis must be evaluated within broader industry consolidation trends and the unique structure of Musk's business portfolio. Unlike traditional corporate mergers, such a combination would represent an unprecedented convergence of multiple high-growth sectors: automotive electrification, space commerce, energy storage, and artificial intelligence.
Tesla currently trades at valuations reflecting expectations of continued automotive dominance and energy business expansion. $TSLA shares have experienced significant volatility amid shifting interest rate expectations, competition from legacy automakers entering the EV space, and concerns regarding Tesla's saturation in mature markets. The introduction of vertical semiconductor manufacturing could materially improve long-term gross margins across product lines while reducing supply chain risk—factors that traditional auto industry investors understand and value.
The semiconductor industry backdrop reinforces the strategic logic. With artificial intelligence deployment accelerating across enterprise, consumer, and government sectors, demand for high-performance chips far exceeds current production capacity. Established foundries including TSMC and Samsung are operating near maximum utilization, with lead times extending across quarters. A vertically integrated manufacturer with Tesla's scale and SpaceX's specialized computing requirements could command significant pricing power and reliability premiums.
The merger speculation also reflects broader market fascination with Musk's multi-enterprise strategy. Unlike traditional conglomerates, Musk's various ventures share technological and operational synergies rather than mere financial portfolio diversification. SpaceX's Starlink satellite internet, for instance, requires sophisticated ground computing and edge AI capabilities that align naturally with Tesla's autonomous vehicle ambitions.
Investor Implications and Valuation Concerns
Ives' $600 price target on $TSLA implies significant upside potential for investors bullish on the merger thesis and accelerated earnings growth from Terafab and ancillary initiatives. At that valuation, Tesla would command approximately 2.5x sales multiples—still below historical peak valuations but substantially elevated from current levels. The analyst base appears to interpret Terafab as a transformative initiative that could add meaningful long-term value through both margin expansion and new revenue streams.
Conversely, Gary Black's caution regarding 20-25% stock dilution reflects a legitimate shareholder concern. A SpaceX-Tesla merger would almost certainly involve new equity issuance to SpaceX shareholders, potentially on favorable terms given SpaceX's recent $180 billion+ valuation. Existing Tesla shareholders would face immediate ownership dilution, though this would theoretically be offset by upside from combined entity synergies and growth acceleration.
The core tension for long-term Tesla equity investors centers on strategic focus. Tesla's original investment thesis emphasized disciplined capital allocation toward electric vehicle and energy storage dominance. A SpaceX merger would substantially broaden that mission, introducing aerospace manufacturing, satellite internet operations, and space-grade computing into Tesla's corporate structure. Some investors specifically allocated to Tesla based on pure-play EV exposure; for these shareholders, broader conglomerate structure represents mission drift and potential discount to valuation.
Forward-Looking Considerations
The 2027 merger timeline offered by Ives suggests a multi-year consolidation process, likely contingent upon successful Terafab ramp-up and demonstration of manufacturing excellence. Tesla's ability to deliver on semiconductor manufacturing promises—a notoriously capital-intensive and technically demanding sector—will significantly influence market confidence in broader strategic plans.
RegulatoryEnvironment also warrants monitoring. A Tesla-SpaceX combination would trigger antitrust scrutiny given the combined entity's diversified technological capabilities and market influence. Government approval—particularly from the Committee on Foreign Investment in the United States (CFIUS) and international regulators—remains uncertain, particularly given SpaceX's extensive aerospace and defense contracting.
Market participants should track quarterly Terafab progress disclosures, Tesla's semiconductor hiring and facility expansion announcements, and any public statements from Musk regarding corporate consolidation. Near-term valuation appreciation appears contingent upon investor conviction that chip manufacturing represents a genuinely transformative strategic pivot, not merely a capital-intensive distraction from automotive core competency.
The $600 price target against Black's dilution warnings encapsulates the fundamental disagreement: whether Tesla shareholders benefit from conglomerate-style expansion into adjacent technologies or whether corporate focus on pure-play EV excellence represents superior long-term value creation. The market will ultimately resolve this debate through stock performance once actual results emerge from Terafab and clarification arrives regarding merger intentions.